© 2012 Future Path Medical Holding Company, LLC All Rights Reserved
Future Path Medical (FPMHC, LLC) is still accepting new investors and strategic partners. We are currently a pre-revenue company with a disruptive patented offering in a mature market. Request a prospectus below.
Within the market, clinical fluid management technology includes solutions for incontinence, bladder and urine monitoring, and hydration management through intravenous delivery. These solution areas will experience significant increases to both patient safety and nursing productivity.
FPMHC, LLC is launching two new families of "Urological Monitoring" products based on expert industrial design, wireless transmission and low-cost sensor technologies. The UroSense™ Essential product family will targeted at home care (e.g. the spinal cord injured, quadriplegic disabled market) and UroSense™ Critical will be targeted for the needs of the “intensivist” and the hospital intensive care unit (ICU) nursing and staff.
We have studies outlining projected volumes for disposables, required system components and potential integration issues. We are certain the management team's focus and our patent pending innovation in UroSense™ Essential and UroSense™ Critical will have a positive impact on healthcare and more specifically hospital buying decision drivers, which we believe to be economics, regulatory compliance, an attractive workplace and patient safety.
The Future Path Medical (FPMHC, LLC) UroSense™ product families consist of innovative patented technologies. Innovations in these families include; industrial designed disposables engineered to specific uses in either the home market or the intensive care unit. FPMHC, LLC has detailed the processes dealing with urine handling in these markets and created patent pending low-cost sensors, a Wi-Mitter™ wireless system that converts urine fill and temperature data into time-stamped “IP” (or Internet protocol). The previously unavailable or expensive data is now offered at a fraction of the cost of any current smart “clinical fluid” systems and allows patient and fluid information to be available anywhere.
The technology is currently going through the FDA 510 K compliance process. Future Path Medical (FPMHC, LLC) is still accepting new investors and strategic partners. We are currently a pre-revenue company with a patented disruptive offering in a mature market.
Send Investment Inquiries to - email@example.com or Click below